PHILADELPHIA, Jan. 30, 2019 /PRNewswire-PRWeb/ -- ControlRad announced changes to its Board of Directors.
Amir Yaron, PhD will be stepping down from the ControlRad Board of Directors due to his appointment as the Governor of the Israeli Bank. Taking his place is David Shulkin, MD, former United States Secretary of the Veterans Affairs. The stature and prestige of these two leaders speaks to the quality of the ControlRad Board of Directors.
"We will miss the valued contributions of Amir to our company's Board of Directors, and fully appreciate why Prime Minister Netanyahu appointed him as Governor of the Israeli Bank," said Guillaume Bailliard, President and CEO, ControlRad. "At the same time, we are thrilled that David has rejoined our board. His experience in leading healthcare systems will bring tremendous value to the company as we move into a commercial phase."
Dr. Shulkin has long been a leader in healthcare management and policy having spent much of his professional career advancing patient safety and quality in healthcare. At the VA, Dr. Shulkin headed the largest integrated healthcare system in the United States, providing care at 1,250 health care facilities, including 172 VA Medical Centers and 1,069 outpatient sites of care.
In the private sector, he served as the President and Chief Executive Officer of Beth Israel Medical Center in New York City, and as Chief Medical Officer of the University of Pennsylvania Health System, the Hospital of the University of Pennsylvania, Temple University Hospital, and the Medical College of Pennsylvania Hospital. Dr. Shulkin has also served as Chairman of Medicine and Vice Dean at Drexel University College of Medicine, and Professor of Medicine at Albert Einstein College of Medicine.
A board-certified internist, Dr. Shulkin is also a Fellow of the American College of Physicians. He received his medical degree from the Medical College of Pennsylvania and completed his internship at Yale University School of Medicine and a fellowship in General Medicine at the University of Pittsburgh Presbyterian Medical Center. He also received advanced training in outcomes research and economics as a Robert Wood Johnson Foundation Clinical Scholar at the University of Pennsylvania.
Modern Healthcare named Dr. Shulkin as one of the "50 Most Influential Physician Executives in the Country" in 2017.
About ControlRad
ControlRad is a privately held medical technology company developing innovative products that dramatically reduce the lifetime risk of radiation exposure from fluoroscopically guided interventional procedures (FGIP) for patients and healthcare professionals. These products are designed to improve safety without compromising image quality or workflow. This is accomplished with an integrated set of proprietary components, which optimize the X-ray beam to deliver optimal image quality in the clinically-relevant region while maintaining appropriate resolution in the periphery. ControlRad is headquartered in Philadelphia and has engineering development facilities in Kfar Saba, Israel. For more information, visit https://www.controlrad.com.
SOURCE ControlRad
Share this article